Summary

The global ophthalmic equipment market is projected to reach USD 80.9 Billion by 2027 from USD 63.4 Billion in 2022, at a CAGR of 5.0%. The growth of this market can largely be attributed to the increase in elderly population, rise in adoption of digital devices, and increasing prevalence of vision disorders.

“The vision care products segment accounted for the largest share of the ophthalmic equipment market, in 2021.”
Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of vision care products segment is attributed to rising demand for different type of eyeglass lenses, the growing prevalence of myopia, and growing geriatric population.

“The consumer segment hold the largest share in the ophthalmic equipment market, by end user”
Based on end users, the ophthalmic equipment market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to factors such as the increasing prevalence of eye disorders among the geriatric population, increasing usage of digital gadgets, and growing adoption of spectacles and contact lenses among consumers.

“The APAC to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. Some of the major factors that are expected to drive the growth of the ophthalmic equipment market in the Asia Pacific region are the significant growth opportunities for ophthalmology device manufacturers in China and India, and significant demand for spectacles & contact lenses. Moreover, with developed economies reaching saturation, manufacturers and suppliers are expected to focus on Asian markets.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Key players in the Ophthalmic Equipment Market

The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

Research Coverage:
The report analyzes the ophthalmic equipment market and aims at estimating the market size and future growth potential of this market based on various segments such as product, end user, and region.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the ophthalmic equipment market. The report analyzes this market by product, and by end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the ophthalmic equipment market
• Market Development: Comprehensive information on the lucrative emerging markets by product, and end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ophthalmic equipment market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and competitive leadership mapping in the ophthalmic equipment market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 50
1.1 STUDY OBJECTIVES 50
1.2 MARKET DEFINITION AND SCOPE 50
1.2.1 INCLUSIONS AND EXCLUSIONS 51
1.3 MARKET SCOPE 52
1.3.1 MARKETS COVERED 52
FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION 52
1.3.2 MARKETS COVERED – BY REGION 53
1.3.3 YEARS CONSIDERED 53
1.4 CURRENCY CONSIDERED 54
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 54
1.5 STAKEHOLDERS 54
1.6 SUMMARY OF CHANGES 55
2 RESEARCH METHODOLOGY 56
2.1 RESEARCH DATA 56
FIGURE 2 RESEARCH DESIGN 56
2.1.1 SECONDARY DATA 56
2.1.1.1 Key data from secondary sources 57
2.1.2 PRIMARY DATA 58
FIGURE 3 PRIMARY SOURCES 59
2.1.2.1 Key data from primary sources 60
2.1.2.2 Key industry insights 60
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 61
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS 61
2.2 MARKET SIZE ESTIMATION 62
FIGURE 6 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 62
FIGURE 7 BOTTOM-UP APPROACH: VISION CARE PRODUCTS COMPANY REVENUE ESTIMATION APPROACH 63
FIGURE 8 BOTTOM-UP APPROACH: OPHTHALMIC SURGICAL EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH 63
FIGURE 9 BOTTOM-UP APPROACH: OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH 64
2.2.1 CAGR PROJECTIONS 65
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 65
2.2.2 TOP-DOWN APPROACH 66
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ON MARKET GROWTH AND CAGR 67
 
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 68
FIGURE 12 DATA TRIANGULATION METHODOLOGY 68
2.4 MARKET SHARE ANALYSIS 69
2.5 RESEARCH ASSUMPTIONS 69
2.6 LIMITATIONS 70
2.6.1 METHODOLOGY-RELATED LIMITATIONS 70
2.6.2 SCOPE-RELATED LIMITATIONS 70
2.7 RISK ASSESSMENT 70
TABLE 2 RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET 70
3 EXECUTIVE SUMMARY 71
FIGURE 13 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 71
FIGURE 14 OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2022 VS. 2027(USD MILLION) 72
FIGURE 15 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION) 73
FIGURE 16 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 74
FIGURE 17 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 75
FIGURE 18 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION) 76
FIGURE 19 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 77
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET 78
4 PREMIUM INSIGHTS 79
4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW 79
FIGURE 21 INCREASING EYE DISORDERS AND RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 79
4.2 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND END USER (2021) 80
FIGURE 22 CONSUMERS TO DOMINATE NORTH AMERICAN OPHTHALMIC EQUIPMENT MARKET IN 2021 80
4.3 OPHTHALMIC EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 81
FIGURE 23 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2022 TO 2027 81
4.4 OPHTHALMIC EQUIPMENT MARKET, BY REGION (2020–2027) 81
FIGURE 24 NORTH AMERICA TO DOMINATE MARKET UNTIL 2027 81
4.5 OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 82
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 82
 
5 MARKET OVERVIEW 83
5.1 INTRODUCTION 83
5.2 MARKET DYNAMICS 84
FIGURE 26 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 84
5.2.1 DRIVERS 84
5.2.1.1 Increasing geriatric population 84
TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050 85
5.2.1.2 Rising prevalence of eye disorders 85
TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2021 (IN MILLION) 86
5.2.1.2.1 Cataracts 86
TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2020 VS 2021) 86
5.2.1.2.2 Glaucoma 86
TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS 2040 (IN MILLION) 87
5.2.1.2.3 Obesity and diabetes 87
TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS 2045 (MILLION) 87
5.2.1.2.4 Age-related macular degeneration (AMD) 88
TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS 2050 (MILLION) 88
5.2.1.3 Technological advancements in ophthalmic devices 88
TABLE 9 RECENT PRODUCT LAUNCHES IN OPHTHALMIC EQUIPMENT MARKET (2019–2021) 89
5.2.1.4 Increased government initiatives to control visual impairment 89
5.2.1.5 Rising adoption of contact lenses and spectacles 90
TABLE 10 PREVALENCE AND PATIENT POPULATION FOR MYOPIA, 2020–2050 90
5.2.2 RESTRAINTS 91
5.2.2.1 High cost and risk associated with eye surgeries 91
5.2.2.2 Increased cost of ophthalmology devices 91
TABLE 11 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2021) 92
5.2.2.3 Rising adoption of refurbished ophthalmic devices 92
5.2.3 OPPORTUNITIES 93
5.2.3.1 Potential growth opportunities in emerging markets 93
5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging regions 93
5.2.4 CHALLENGES 94
5.2.4.1 Low accessibility to eye care in low-income countries 94
5.2.4.2 Lack of skilled professionals 94
 
6 INDUSTRY INSIGHTS 96
6.1 INDUSTRY TRENDS 96
6.1.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY 96
6.1.2 TECHNOLOGICAL ADVANCEMENT IN INTRAOCULAR LENSES 96
6.1.3 MINIMALLY INVASIVE GLAUCOMA SURGERY 97
6.2 PRICING ANALYSIS 97
TABLE 12 REGIONAL PRICING ANALYSIS OF OPHTHALMIC EQUIPMENT, 2021 (USD) 98
6.2.1 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS 98
TABLE 13 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD) 98
6.2.2 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS 98
TABLE 14 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD) 98
6.2.3 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS 99
TABLE 15 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD) 99
6.3 PATENT ANALYSIS 99
6.3.1 PATENT PUBLICATION TRENDS FOR OPHTHALMIC EQUIPMENT 99
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011– AUGUST 2022) 100
6.3.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 100
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR OPHTHALMIC EQUIPMENT PATENTS (JANUARY 2011–AUGUST 2022) 101
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR OPHTHALMIC EQUIPMENT (JANUARY 2011–AUGUST 2022) 102
TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS IN OPHTHALMIC EQUIPMENT MARKET, 2021–2022 102
6.4 VALUE CHAIN ANALYSIS 104
FIGURE 30 OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 104
6.5 SUPPLY CHAIN ANALYSIS 105
FIGURE 31 OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 106
6.6 ECOSYSTEM ANALYSIS 106
TABLE 17 OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM MAPPING 107
TABLE 18 OPHTHALMIC EQUIPMENT MARKET: ROLE IN ECOSYSTEM 108
6.7 PORTER’S FIVE FORCES ANALYSIS 109
TABLE 19 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 109
6.7.1 THREAT OF NEW ENTRANTS 109
6.7.2 THREAT OF SUBSTITUTES 109
6.7.3 BARGAINING POWER OF BUYERS 110
6.7.4 BARGAINING POWER OF SUPPLIERS 110
6.7.5 DEGREE OF COMPETITION 110
6.8 REGULATORY ANALYSIS 110
6.8.1 NORTH AMERICA 110
6.8.1.1 US 110
6.8.1.2 Canada 111
6.8.2 EUROPE 111
6.8.3 ASIA PACIFIC 111
6.8.3.1 China 111
6.8.3.2 Japan 112
6.8.3.3 India 112
6.8.4 LATIN AMERICA 112
6.8.4.1 Brazil 113
6.8.4.2 Mexico 113
6.8.5 MIDDLE EAST 113
6.8.6 AFRICA 113
6.9 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 23 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
6.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 116
6.10.1 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGICAL ADVANCED OPHTHALMIC EQUIPMENT DUE TO COVID-19 PANDEMIC 116
FIGURE 32 REVENUE SHIFT IN OPHTHALMIC EQUIPMENT MARKET 116
6.11 TRADE ANALYSIS 117
6.11.1 TRADE ANALYSIS FOR OPHTHALMIC EQUIPMENT PRODUCTS 117
TABLE 24 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 117
TABLE 25 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 117
6.12 KEY CONFERENCES AND EVENTS IN 2022−2023 118
TABLE 26 OPHTHALMIC EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 118
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 119
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 119
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 119
TABLE 27 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 119
6.13.2 BUYING CRITERIA 120
FIGURE 34 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 120
TABLE 28 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 120
6.14 CASE STUDY 121
 
7 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT 122
7.1 INTRODUCTION 123
TABLE 29 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123
7.2 VISION CARE PRODUCTS 123
TABLE 30 VISION CARE PRODUCTS OFFERED BY KEY PLAYERS 124
TABLE 31 OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 32 OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 125
7.2.1 SPECTACLES 126
7.2.1.1 Rising adoption of digital devices to drive market 126
TABLE 33 SPECTACLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
7.2.2 CONTACT LENSES 127
TABLE 34 CONTACT LENSES OFFERED BY KEY PLAYERS 128
TABLE 35 CONTACT LENSES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 36 CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
7.2.2.1 Soft contact lenses 130
7.2.2.1.1 Increasing prevalence of myopia to propel adoption 130
TABLE 37 SOFT CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
7.2.2.2 RGP lenses 131
7.2.2.2.1 Increased usage of lenses to correct irregularly shaped corneas to drive demand 131
TABLE 38 RIGID GAS PERMEABLE LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
7.2.2.3 Hybrid Contact Lenses 133
7.2.2.3.1 Hybrid lenses to provide advantages over soft and rigid lenses 133
TABLE 39 HYBRID CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
7.3 SURGICAL DEVICES 134
TABLE 40 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 41 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 135
7.3.1 CATARACT SURGICAL DEVICES 135
TABLE 42 CATARACT SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 43 CATARACT SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 136
7.3.1.1 Intraocular lenses 137
7.3.1.1.1 Rising prevalence of cataracts globally to propel segment 137
TABLE 44 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS 138
TABLE 45 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
7.3.1.2 Ophthalmic viscoelastic devices 139
7.3.1.2.1 Increasing cataract surgeries to support market 139
TABLE 46 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
7.3.1.3 Phacoemulsification devices 141
7.3.1.3.1 Advancements in phacoemulsification devices to increase demand 141
TABLE 47 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
7.3.1.4 Cataract surgical lasers 143
7.3.1.4.1 Accuracy and safety of femtosecond laser technology to drive demand 143
TABLE 48 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
7.3.1.5 IOL injectors 145
7.3.1.5.1 Rising need for accurate implantation to boost market 145
TABLE 49 IOL INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 50 IOL INJECTORS OFFERED BY KEY PLAYERS 146
7.3.2 VITREORETINAL SURGICAL DEVICES 147
TABLE 51 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 52 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
7.3.2.1 Vitrectomy machines 148
7.3.2.1.1 Vitrectomy machines to correct retinal errors 148
TABLE 53 VITRECTOMY MACHINES OFFERED BY KEY PLAYERS 149
TABLE 54 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 149
7.3.2.2 Vitreoretinal packs 150
7.3.2.2.1 Increasing awareness about vitreoretinal surgery to drive demand 150
TABLE 55 VITREORETINAL PACKS OFFERED BY KEY PLAYERS 150
TABLE 56 VITREORETINAL PACKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
7.3.2.3 Photocoagulation lasers 151
7.3.2.3.1 Rising prevalence of various eye diseases to drive market 151
TABLE 57 PHOTOCOAGULATION LASERS OFFERED BY KEY PLAYERS 152
TABLE 58 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
7.3.2.4 Illumination devices 153
7.3.2.4.1 Portability and power to increase efficiency 153
TABLE 59 ILLUMINATION DEVICES OFFERED BY KEY PLAYERS 153
TABLE 60 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 154
7.3.2.5 Vitrectomy probes 154
7.3.2.5.1 Advancements to rapidly cut speed to remove vitreous bodies 154
TABLE 61 VITRECTOMY PROBES OFFERED BY KEY PLAYERS 155
TABLE 62 VITRECTOMY PROBES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
 
7.3.3 REFRACTIVE SURGICAL DEVICES 156
TABLE 63 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 64 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 157
7.3.3.1 Femtosecond lasers 157
7.3.3.1.1 Preference for femtosecond lasers over microkeratomes to support market 157
TABLE 65 FEMTOSECOND LASERS OFFERED BY KEY PLAYERS 158
TABLE 66 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 159
7.3.3.2 Excimer lasers 159
7.3.3.2.1 Increased occurrence of myopia to drive market 159
TABLE 67 EXCIMER LASERS OFFERED BY KEY PLAYERS 160
TABLE 68 EXCIMER LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 160
7.3.3.3 Other refractive surgical lasers 161
TABLE 69 OTHER REFRACTIVE SURGICAL LASERS OFFERED BY KEY PLAYERS 161
TABLE 70 OTHER REFRACTIVE SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 162
7.3.4 GLAUCOMA SURGICAL DEVICES 162
TABLE 71 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY PLAYERS 163
TABLE 72 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 73 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
7.3.4.1 Microinvasive glaucoma surgery devices 164
7.3.4.1.1 Rising preference for microinvasive glaucoma surgery to drive adoption 164
TABLE 74 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
7.3.4.2 Glaucoma drainage devices 166
7.3.4.2.1 Rising prevalence of glaucoma globally to propel market 166
TABLE 75 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 167
7.3.4.3 Glaucoma laser systems 167
7.3.4.3.1 Increasing prevalence of open-angle glaucoma to drive market 167
TABLE 76 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 168
7.3.5 OPHTHALMIC MICROSCOPES 169
7.3.5.1 Rising occurrence of eye diseases to boost segment 169
TABLE 77 OPHTHALMIC MICROSCOPES OFFERED BY KEY PLAYERS 169
TABLE 78 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
7.3.6 OPHTHALMIC SURGICAL ACCESSORIES 170
TABLE 79 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY PLAYERS 171
TABLE 80 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 81 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
7.3.6.1 Surgical sets & instruments 173
7.3.6.1.1 Surgical sets & instruments to dominate market 173
TABLE 82 SURGICAL SETS & INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 174
7.3.6.2 Ophthalmic tips & handles 174
7.3.6.2.1 Wide range of tips and handles to drive demand 174
TABLE 83 OPHTHALMIC TIPS& HANDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 175
7.3.6.3 Ophthalmic scissors 175
7.3.6.3.1 Titanium scissors to dominate segment 175
TABLE 84 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
7.3.6.4 Ophthalmic forceps 176
7.3.6.4.1 Forceps to be mostly used in ophthalmological surgeries 176
TABLE 85 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 177
7.3.6.5 Ophthalmic spatulas 177
7.3.6.5.1 China to be fastest-growing market for ophthalmic spatulas 177
TABLE 86 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
7.3.6.6 Macular lenses 178
7.3.6.6.1 Increased adoption of macular lenses to drive segment 178
TABLE 87 MACULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 179
7.3.6.7 Ophthalmic cannulas 179
7.3.6.7.1 Rising adoption of single-use cannulas to drive market 179
TABLE 88 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 180
7.3.6.8 Other ophthalmic surgical accessories 180
TABLE 89 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 181
7.4 DIAGNOSTIC & MONITORING DEVICES 181
TABLE 90 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 91 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 183
7.4.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 183
7.4.1.1 OCT scanners to provide high-depth image analysis on real-time basis 183
TABLE 92 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 93 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS 185
7.4.2 FUNDUS CAMERAS 185
7.4.2.1 Rising age-related disorders to drive market 185
TABLE 94 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS 186
TABLE 95 FUNDUS CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 187
7.4.3 PERIMETERS/VISUAL FIELD ANALYZERS 187
7.4.3.1 Increasing incidence of glaucoma and AMD to propel demand 187
TABLE 96 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS 188
TABLE 97 PERIMETERS/ VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 188
7.4.4 AUTOREFRACTORS & KERATOMETERS 189
7.4.4.1 Rising visually impaired patients to drive market 189
TABLE 98 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS 189
TABLE 99 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 190
7.4.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 190
TABLE 100 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 101 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 191
7.4.5.1 A-scan ultrasound imaging systems 192
7.4.5.1.1 Increased usage in cataract surgeries to propel market 192
TABLE 102 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 192
TABLE 103 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 193
7.4.5.2 B-scan ultrasound imaging systems 193
7.4.5.2.1 Assessment of eyes and orbits to detect eye disorders to drive market 193
TABLE 104 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 194
TABLE 105 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 194
7.4.5.3 Opthalmic UBM Ultrasound 195
7.4.5.3.1 Rising volume of refractive surgeries globally to drive market 195
TABLE 106 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS 195
TABLE 107 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 196
7.4.5.4 Ophthalmic Pachymeters 196
7.4.5.4.1 Ophthalmic pachymeters to monitor cornea 196
TABLE 108 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS 197
TABLE 109 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 198
7.4.6 TONOMETERS 198
7.4.6.1 Rising prevalence of glaucoma to drive demand 198
TABLE 110 TONOMETERS OFFERED BY KEY MARKET PLAYERS 199
TABLE 111 TONOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 200
 
7.4.7 SLIT LAMPS 200
7.4.7.1 Rising prevalence of ocular conditions to drive market 200
TABLE 112 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS 201
TABLE 113 SLIT LAMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 202
7.4.8 PHOROPTERS 202
7.4.8.1 Phoropters to measure refractive errors 202
TABLE 114 PHOROPTERS OFFERED BY KEY MARKET PLAYERS 203
TABLE 115 PHOROPTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 204
7.4.9 WAVEFRONT ABERROMETERS 204
7.4.9.1 Aberrometers to measure refractive aberrations 204
TABLE 116 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS 205
TABLE 117 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 205
7.4.10 OPTICAL BIOMETRY SYSTEMS 206
7.4.10.1 Advantages of optical biometry systems to boost diagnostics 206
TABLE 118 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 206
TABLE 119 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 207
7.4.11 OPHTHALMOSCOPES 207
7.4.11.1 Increasing patients with glaucoma, diabetic retinopathy, and AMD to drive market 207
TABLE 120 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS 208
TABLE 121 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 209
7.4.12 LENSMETERS 209
7.4.12.1 Rising prevalence of myopia and hyperopia with increasing adoption of glassware to drive market 209
TABLE 122 LENSMETERS OFFERED BY KEY MARKET PLAYERS 210
TABLE 123 LENSMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 211
7.4.13 CORNEAL TOPOGRAPHY SYSTEMS 211
7.4.13.1 Rising LASIK procedures to propel demand 211
TABLE 124 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS 212
TABLE 125 CORNEAL TOPOGRAPHY SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 212
7.4.14 CHART PROJECTORS 213
7.4.14.1 Eye chart projectors to access different chart types in one device 213
TABLE 126 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS 213
TABLE 127 CHART PROJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 214
7.4.15 SPECULAR MICROSCOPES 214
7.4.15.1 Increasing diabetic patients to drive market 214
TABLE 128 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS 215
TABLE 129 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 215
7.4.16 RETINOSCOPES 216
7.4.16.1 Rising prevalence of myopia globally to boost market 216
TABLE 130 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS 216
TABLE 131 RETINOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 217
8 OPHTHALMIC EQUIPMENT MARKET, BY END USER 218
8.1 INTRODUCTION 219
TABLE 132 OPHTHALMIC EQUIPMENT MARKET BY END USER, 2020–2027 (USD MILLION) 219
8.2 CONSUMERS 219
8.2.1 INCREASING OCULAR DISORDERS WITH RISING ADOPTION OF CONTACT LENSES AND SPECTACLES TO DRIVE MARKET 219
TABLE 133 OPHTHALMIC EQUIPMENT MARKET FOR CONSUMERS, BY COUNTRY, 2020–2027 (USD MILLION) 220
8.3 HOSPITALS 220
8.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER FOR ADVANCED INSTRUMENTS TO PROPEL MARKET 220
FIGURE 35 NUMBER OF HOSPITALS, BY COUNTRY (2019) 221
TABLE 134 OPHTHALMIC EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 222
8.4 SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS 222
8.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO DRIVE MARKET 222
FIGURE 36 US: NUMBER OF AMBULATORY SURGICAL CENTERS (2012-2022) 223
TABLE 135 OPHTHALMIC EQUIPMENT MARKET FOR SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 224
8.5 OTHER END USERS 224
TABLE 136 OPHTHALMIC EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 225
9 OPHTHALMIC EQUIPMENT MARKET, BY REGION 226
9.1 INTRODUCTION 227
FIGURE 37 OPHTHALMIC EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 227
TABLE 137 OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 228
9.2 NORTH AMERICA 228
FIGURE 38 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 229
TABLE 138 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 230
TABLE 139 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 230
TABLE 140 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 141 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 142 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 143 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 144 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 145 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 146 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 147 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 148 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 234
9.2.1 US 235
9.2.1.1 Rising geriatric population and increasing healthcare expenditure to drive market 235
TABLE 149 US: KEY MACROINDICATORS 235
TABLE 150 OCULAR CONDITIONS IN US: 2000–2020 (MILLION) 236
TABLE 151 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 236
TABLE 152 US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 153 US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 154 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 155 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 156 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 157 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 158 US: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 159 US: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 160 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 240
9.2.2 CANADA 241
9.2.2.1 Rising awareness about eye care and increasing ocular diseases to drive market 241
TABLE 161 CANADA: KEY MACROINDICATORS 241
TABLE 162 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 242
TABLE 163 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 164 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 165 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 166 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 167 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 168 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 169 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 170 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 171 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 245
9.3 EUROPE 246
TABLE 172 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 246
TABLE 173 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 247
TABLE 174 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 175 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 176 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 177 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 178 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 179 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 180 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 181 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 182 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 250
9.3.1 GERMANY 251
9.3.1.1 Increasing healthcare expenditure to boost market 251
TABLE 183 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 251
TABLE 184 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 185 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 186 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 187 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 188 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 189 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 190 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 191 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 192 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 255
9.3.2 UK 256
9.3.2.1 Rising prevalence of diabetes-related eye diseases to drive market 256
TABLE 193 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 256
TABLE 194 UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 195 UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 196 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 197 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 198 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 199 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 200 UK: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 201 UK: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 202 UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 260
9.3.3 FRANCE 261
9.3.3.1 Growing eye surgeries to drive demand 261
TABLE 203 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 261
TABLE 204 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 205 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 206 FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 207 FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 208 FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 209 FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 210 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 211 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 212 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 265
9.3.4 ITALY 266
9.3.4.1 Increasing healthcare spending and growing geriatric population to propel market 266
TABLE 213 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 266
TABLE 214 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION) 267
TABLE 215 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 216 ITALY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 217 ITALY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 218 ITALY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 219 ITALY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 220 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 221 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 222 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 270